Surrozen (SRZN) EBITDA Margin (2021 - 2026)
Surrozen's EBITDA Margin came in at -206.38% for Q2 2026, up 696.98 percentage points from -903.36% a year earlier and up 1.44 percentage points from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) EBITDA Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Surrozen reported EBITDA Margin of -383.36%, down 186.60 percentage points year-over-year; for FY2025, it came in at -1195.14%, down 968.98 percentage points from FY2024.
- EBITDA Margin carries a three-year change of -856.43 percentage points (FY2022 to FY2025).
- Going back by year, EBITDA Margin was -226.16% in FY2024 and -338.71% in FY2022.
- The Q2 2026 figure represents the highest quarterly EBITDA Margin since Q3 2024.
- Year-over-year, EBITDA Margin increased in two of the last four quarters, with an average year-over-year change of -202.16 percentage points.
- Business Quant data shows SRZN's EBITDA Margin at -207.82% (Q1 2026), -2385.23% (Q4 2025) and -1101.12% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 39.16% |
| 10 | Surrozen | 294.61 Mn | -84.92 Mn | - | -206.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -206.38% |
| Mar 31, 2026 | -207.82% |
| Dec 31, 2025 | -2,385.23% |
| Sep 30, 2025 | -1,101.12% |
| Jun 30, 2025 | -903.36% |
| Mar 31, 2025 | -941.71% |
| Dec 31, 2024 | -1,262.60% |
| Sep 30, 2024 | 15.74% |
| Sep 30, 2021 | -94,142.86% |
API Access
Surrozen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();